Search Results - "Eom, Hyeon Seok"

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma by Ansell, Stephen M., Radford, John, Connors, Joseph M., Długosz-Danecka, Monika, Kim, Won-Seog, Gallamini, Andrea, Ramchandren, Radhakrishnan, Friedberg, Jonathan W., Advani, Ranjana, Hutchings, Martin, Evens, Andrew M., Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Eom, Hyeon-Seok, Abramson, Jeremy S., Dong, Cassie, Campana, Frank, Fenton, Keenan, Puhlmann, Markus, Straus, David J.

“…The replacement of bleomycin with the immune drug conjugate brentuximab vedotin in the first-line chemotherapy regimen for advanced Hodgkin’s lymphoma…”
Get full text

Prediction of clinical outcomes through assessment of sarcopenia and adipopenia using computed tomography in adult patients with acute myeloid leukemia by Jung, Jongheon, Lee, Eunyoung, Shim, Hyoeun, Park, Ju-Hyun, Eom, Hyeon-Seok, Lee, Hyewon

“…Sarcopenia and adipopenia have prognostic significance in cancer. Analysis of a single abdominal computed tomography (CT) section at the third lumbar vertebra…”
Get full text

Guillain-Barré syndrome after vaccination against COVID-19 by Chun, June Young, Park, Sohyun, Jung, Jongheon, Kim, Su-Hyun, Kim, Tae-Sung, Choi, Young Ju, Kim, Ho Jin, Eom, Hyeon-Seok, Hyun, Jae-Won

“…Mild-to-moderate irregular increased 18F-FDG uptake along a neurovascular bundle was observed (figure, video). Since the initial clinical manifestation in…”
Get full text

4-1BB immunotherapy: advances and hurdles by Singh, Rohit, Kim, Young-Ho, Lee, Sang-Jin, Eom, Hyeon-Seok, Choi, Beom K.

“…Since its initial description 35 years ago as an inducible molecule expressed in cytotoxic and helper T cells, 4-1BB has emerged as a crucial receptor in…”
Get full text

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma by Jung, Jongheon, Lee, Hyewon, Heo, Ja Yoon, Chang, Myung Hee, Lee, Eunyoung, Park, Weon Seo, Park, Ju-Hyun, Eom, Hyeon-Seok

“…The C-reactive protein-to-albumin ratio (CAR) has not been assessed in diffuse large B cell lymphoma (DLBCL, the most common non-Hodgkin lymphoma). This…”
Get full text

Elevated Red Blood Cell Distribution Width as a Simple Prognostic Factor in Patients with Symptomatic Multiple Myeloma by Eom, Hyeon-Seok, Lee, Sangeun, Youn, Hye Sun, Kim, Hyun Ju, Shim, Hyoeun, Sohn, Ji Yeon, Lee, Hyewon, Kong, Sun-Young

“…Red blood cell distribution width (RDW) is a parameter reported in complete blood cell count tests, and has been reported as an inflammatory biomarker…”
Get full text

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study) by Lee, Ho Sup, Kim, Kihyun, Kim, Seok Jin, Lee, Je‐Jung, Kim, Inho, Kim, Jin Seok, Eom, Hyeon‐Seok, Yoon, Dok Hyun, Suh, Cheolwon, Shin, Ho‐Jin, Mun, Yeung‐Chul, Kim, Min Kyoung, Lim, Sung‐Nam, Choi, Chul Won, Kang, Hye Jin, Yoon, Sung‐Soo, Min, Chang‐Ki

“…Patients with transplant‐ineligible relapsed and refractory multiple myeloma (RRMM) have a short life expectancy, especially when they have failed both the…”
Get full text

Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma by Jung, Jongheon, Heo, Ja Yoon, Lee, Eunyoung, Lee, Hyewon, Chang, Myung Hee, Park, Ju-Hyun, Eom, Hyeon-Seok

“…Purpose Peripheral T-cell lymphoma (PTCL) is an aggressive and heterogenous T-cell lymphoid malignancy. The prognostic value of C-reactive protein-to-albumin…”
Get full text

Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies by Lee, Eunyoung, Koh, Youngil, Hong, Junshik, Eom, Hyeon Seok, Yoon, Sung Soo

“…Acute myeloid leukemia (AML) is a complicated disease characterized by genetic heterogeneity and simultaneous alterations in multiple genes. For decades, its…”
Get full text

Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients by Kong, Jung Hee, Hu, Youmi, Kong, Sun‐Young, Lee, Se‐Na, Eom, Hyeon‐Seok, Lee, Hyewon, Lee, Eunyoung, Shim, Hyoeun

“…Background Peripheral blood stem cell (PBSC) collection is important for successful hematopoietic stem cell transplantation. This study aimed to investigate…”
Get full text

Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805) by Kim, Kihyun, Kim, Jin Seok, Yoon, Sung-Soo, Yoon, Dok Hyun, Eom, Hyeon-Seok, Lee, Je-Jung, Yim, Hyeon Woo, Park, Misun, Lee, Hojoon, Min, Chang-Ki

“…Optimal treatments for multiple myeloma (MM) patients with high-risk cytogenetics must be determined, but subgroup features are not well-defined. We used…”
Get full text

Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection by Chung, Yousun, Kong, Jung Hee, Hu, Youmi, Lee, Se‐Na, Shim, Hyoeun, Eom, Hyeon‐Seok, Kong, Sun‐Young

“…Introduction Autologous peripheral blood stem cell (PBSC) transplantation has become a standard treatment option for many oncology patients. The aim of this…”
Get full text

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial by Yhim, Ho-Young, Yoon, Dok Hyun, Kim, Seok Jin, Yang, Deok-Hwan, Eom, Hyeon-Seok, Kim, Kyoung Ha, Park, Yong, Kim, Jin Seok, Kim, Hyo Jung, Suh, Cheolwon, Kim, Won Seog, Kwak, Jae-Yong

“…There are limited data from prospective controlled trials regarding optimal treatment strategies in patients with primary breast diffuse large B-cell lymphoma…”
Get full text

Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation by Jung, Jongheon, Lee, Hyewon, Suh, Yang Gun, Eom, Hyeon Seok, Lee, Eunyoung

“…Total body irradiation (TBI) is included in the conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT), with unique advantages such…”
Get full text

Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis by Hong, Jung Yong, Yoon, Dok Hyun, Yoon, Sang Eun, Kim, Seok Jin, Lee, Ho Sup, Eom, Hyeon-Seok, Lee, Hye Won, Shin, Dong-Yeop, Koh, Youngil, Yoon, Sung-Soo, Jo, Jae-Cheol, Kim, Jin Seok, Kim, Soo-Jeong, Cho, Su-Hee, Lee, Won-Sik, Won, Jong-Ho, Kim, Won Seog, Suh, Cheolwon

“…Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of non-Hodgkin’s lymphomas with poor clinical outcomes. Pralatrexate showed efficacy and safety in…”
Get full text

Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study by Jung, Jongheon, Choi, Yoon Seok, Lee, Jae Hoon, Lee, Won Sik, Kim, Sung-hyun, Park, Yong, Lee, Seung-Shin, Do, Young Rok, Jo, Jae-Cheol, Lee, Je-Jung, Kim, Jin Seok, Shin, Ho-Jin, Shin, Dong-Yeop, Yoon, Sung-Soo, Min, Chang-Ki, Kim, Kihyun, Eom, Hyeon-Seok

“…Autologous stem cell transplantation (ASCT) is not frequently performed for elderly patients multiple myeloma (MM) in Korea, despite its being a standardized…”
Get full text

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice by Park, Sung-Soo, Eom, Hyeon-Seok, Kim, Jin Seok, Koh, Youngil, Choi, Chul Won, Lee, Je-Jung, Kim, Kihyun, Suh, Cheolwon, Lee, Jae Hoon, Min, Chang-Ki

“…Despite the recently reported efficacy of daratumumab monotherapy for patients with relapsed or refractory multiple myeloma, outcomes in real practice…”
Get full text

S311: EFFICACY OF INTRAVENOUS IRON TREATMENT FOR CANCER PATIENT WITH ANEMIA, RANDOMIZED CONTROLLED STUDY by Ho Jang, Jun, Park, Kyunghwa, Yong Oh, Sung, Woo Lee, Hyun, Eom, Hyeon‐Seok

Get full text

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone by Lee, Ho Sup, Kim, Kihyun, Lee, Je-Jung, Yoon, Sung-Soo, Bang, Soo-Mee, Kim, Jin Seok, Eom, Hyeon-Seok, Yoon, Dok Hyun, Lee, Yoojin, Shin, Ho-Jin, Park, Yong, Jo, Jae-Cheol, Lee, Won Sik, Do, Young Rok, Mun, Yeung-Chul, Lee, Mark Hong, Kim, Hyo Jung, Kim, Sung-Hyun, Kim, Min Kyoung, Lim, Sung-Nam, Park, Seong Kyu, Yi, Jun Ho, Lee, Jae Hoon, Min, Chang-Ki

“…We compared efficacy and safety, according to frailty, of elderly patients with relapsed and refractory multiple myeloma (RRMM) treated with lenalidomide and…”
Get full text

Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study by Baek, Dong Won, Park, Han-Seung, Sohn, Sang Kyun, Kim, Dae Young, Kim, Inho, Ahn, Jae-Sook, Do, Young Rok, Lee, Se Ryeon, Eom, Hyeon-Seok, Lee, Won-Sik, Kim, Sung-Hyun, Lee, Ho Sup, Lee, Yoo Jin, Moon, Joon Ho, Lee, Je-Hwan

“…We performed a prospective study to determine the efficacy and safety of rituximab including chemotherapy in CD20-positive acute lymphoblastic leukemia (ALL)…”
Get full text